Earnings Feed
Start Free
MYRIAD GENETICS INC·4

Mar 1, 4:55 PM ET

Hart Jayne B. 4

4 · MYRIAD GENETICS INC · Filed Mar 1, 2022

Insider Transaction Report

Form 4
Period: 2022-02-28
MYRIAD GENETICS INCMYGN
Hart Jayne B.
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2022-02-28$23.98/sh+7,000$167,860→ 172,878 total
  • Sale

    Common Stock

    [F1]
    2022-02-28$25.00/sh−7,000$175,000→ 165,878 total
  • Exercise/Conversion

    Common Stock

    [F1][F2]
    2022-02-28$23.98/sh+3,500$83,930→ 169,378 total
  • Sale

    Common Stock

    [F1]
    2022-02-28$25.00/sh−3,500$87,500→ 165,878 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    [F1][F3]
    2022-02-28−3,500→ 0 total
    Exercise: $23.98Exp: 2022-03-07→ Common Stock (3,500 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F1][F3]
    2022-02-28−7,000→ 0 total
    Exercise: $23.98Exp: 2022-03-07→ Common Stock (7,000 underlying)
Footnotes (3)
  • [F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]Represents shares of common stock received upon exercise of a stock option award.
  • [F3]The shares subject to this option are fully vested and exercisable.
Signature
By: Nathan A. Smith For: Jayne B. Hart|2022-03-01

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT